C225 and PDT combination therapy for ovarian cancer: the play's the thing.

Cengel, Keith A

C225 and PDT combination therapy for ovarian cancer: the play's the thing. [electronic resource] - Journal of the National Cancer Institute Oct 2005 - 1488-9 p. digital

Publication Type: Editorial; Comment

1460-2105

10.1093/jnci/dji360 doi


Animals
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--pharmacology
Carcinoma--drug therapy
Cetuximab
Drug Synergism
ErbB Receptors--drug effects
Female
Hematoporphyrin Photoradiation--methods
Immunotherapy--methods
Injections, Intraperitoneal
Low-Level Light Therapy--methods
Mice
Ovarian Neoplasms--drug therapy
Peritoneal Neoplasms--drug therapy
Photosensitizing Agents--pharmacology
Porphyrins--pharmacology
Transplantation, Heterologous
Tumor Cells, Cultured